Joe E. Kiani Sells 869 Shares of Masimo Corp. (MASI) Stock
Masimo Corp. (NASDAQ:MASI) CEO Joe E. Kiani sold 869 shares of the company’s stock in a transaction that occurred on Tuesday, November 22nd. The shares were sold at an average price of $62.00, for a total value of $53,878.00. Following the transaction, the chief executive officer now directly owns 119,241 shares of the company’s stock, valued at $7,392,942. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Shares of Masimo Corp. (NASDAQ:MASI) traded up 0.50% during trading on Wednesday, reaching $62.09. The company’s stock had a trading volume of 229,396 shares. The company’s 50-day moving average is $59.23 and its 200-day moving average is $55.42. The company has a market capitalization of $3.08 billion, a P/E ratio of 29.98 and a beta of 0.98. Masimo Corp. has a 12 month low of $33.03 and a 12 month high of $62.29.
Masimo Corp. (NASDAQ:MASI) last released its earnings results on Wednesday, November 2nd. The company reported $0.52 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.42 by $0.10. Masimo Corp. had a net margin of 16.31% and a return on equity of 29.42%. The business earned $167.60 million during the quarter, compared to analysts’ expectations of $165.51 million. During the same quarter last year, the company earned $0.36 earnings per share. The firm’s revenue was up 9.8% on a year-over-year basis. On average, analysts forecast that Masimo Corp. will post $2.14 EPS for the current fiscal year.
A number of equities analysts recently issued reports on the company. Wedbush reissued an “outperform” rating and issued a $75.00 price objective on shares of Masimo Corp. in a report on Monday, November 14th. Zacks Investment Research lowered Masimo Corp. from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 4th. Piper Jaffray Cos. reissued an “overweight” rating and issued a $55.00 price objective (up from $52.00) on shares of Masimo Corp. in a report on Friday, August 5th. Finally, BTIG Research reissued a “hold” rating on shares of Masimo Corp. in a report on Friday, August 5th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $55.00.
Large investors have recently added to or reduced their stakes in the stock. D.A. Davidson & CO. boosted its stake in Masimo Corp. by 42.8% in the third quarter. D.A. Davidson & CO. now owns 1,713 shares of the company’s stock valued at $101,000 after buying an additional 513 shares during the last quarter. Victory Capital Management Inc. boosted its position in shares of Masimo Corp. by 76.9% in the second quarter. Victory Capital Management Inc. now owns 2,148 shares of the company’s stock worth $113,000 after buying an additional 934 shares in the last quarter. Acrospire Investment Management LLC boosted its position in shares of Masimo Corp. by 22.2% in the third quarter. Acrospire Investment Management LLC now owns 2,200 shares of the company’s stock worth $131,000 after buying an additional 400 shares in the last quarter. Tower Research Capital LLC TRC acquired a new position in shares of Masimo Corp. during the second quarter worth approximately $116,000. Finally, First Quadrant L P CA acquired a new position in shares of Masimo Corp. during the third quarter worth approximately $138,000. Institutional investors and hedge funds own 82.77% of the company’s stock.
About Masimo Corp.
Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring.
Receive News & Stock Ratings for Masimo Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corp. and related stocks with our FREE daily email newsletter.